title: [Propranolol for prophylaxis of migraine (author's transl)].
abstract: The prophylactic effectiveness of propranolol (80 to 120 mg per day) in 18 migraine patients was compared with a placebo group of 19 migraine patients in a double blind study without cross over for a treatment period of six and twelve weeks. A statistically significant difference in effect could not be ascertained. The results and methodological assumptions of the double blind studies with cross over already under consideration in the literature are discussed.
mesh_terms: D002986:Clinical Trials as Topic; D006801:Humans; D008433:Mathematics; D008881:Migraine Disorders / Q000517:prevention & control*; D010919:Placebos; D011433:Propranolol / Q000008:administration & dosage / Q000627:therapeutic use*; D013997:Time Factors
chemical_list: D010919:Placebos; D011433:Propranolol
vernacular_title: Propranolol in der Migräneprophylaxe. Eine Doppelblindstudie.